Skip to main content
Log in

Bacterial and fungal growth in total parenteral nutrition solutions

  • Published:
Antonie van Leeuwenhoek Aims and scope Submit manuscript

Abstract

The most serious complication of prolonged intravenous infusion of hypertonic dextrose and amino acids is infection. Frequently, the etiology is fungal rather than bacterial. Previous authors have suggested that bacterial survival and growth in the solutions is suppressed by (a) high dextrose concentration, (b) high osmolality, or (c) low pH. This paper presents evidence that proposals (a) and (b) are untenable and (c) is only partly responsible. We call attention to the presence of a factor that is antibacterial but not antifungal; namely, a high concentration of glycine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Barlow, A. J. E., Aldersley, T. andChattaway, F. W. 1974. Factors present in serum and seminal plasma which promote germ-tube formation and mycelial growth ofCandida albicans.—J. Gen. Microbiol.82: 261–272.

    PubMed  CAS  Google Scholar 

  • Brennan, M. F., O'Connell, R. C., Rosol, J. A. andKundsin, R. 1971. The growth ofCandida albicans in nutritive solutions given parenterally.—Arch. Surg.103: 705–708.

    PubMed  CAS  Google Scholar 

  • Craddock, P. R., Yawata, Y., Van Santen, L., Gilberstadt, S., Silvis, S. andJacob, H. S. 1974. Acquired phagocyte dysfunction. A complication of the hypophosphatemia of parenteral hyperalimentation.—New Eng. J. Med.290: 1403–1407.

    Article  PubMed  CAS  Google Scholar 

  • Deef, E. N. andNatsios, G. A. 1971. Contamination of intravenous fluids by bacteria and fungi during preparation and administration.—Amer. J. Hosp. Pharm.28: 765–767.

    Google Scholar 

  • Gelbart, S. M., Reinhardt, G. F. andGreenlee, H. B. 1973. Multiplication of nosocomial pathogens in intravenous feeding solutions.—Appl. Microbiol.26: 874–879.

    PubMed  CAS  Google Scholar 

  • Goldmann, D. A. andMaki, D. G. 1973. Infection control in total parenteral nutrition.—J. Amer. Med. Assn.223: 1360–1364.

    Article  CAS  Google Scholar 

  • Goldmann, D. A., Martin, W. T. andWorthington, J. W. 1973. Growth of bacteria and fungi in total parenteral nutrition solutions.—Amer. J. Surg.126: 314–318.

    Article  PubMed  CAS  Google Scholar 

  • Hammes, W., Schleifer, K. H. andKandler, O. 1973. Mode of action of glycine on the biosynthesis of peptidoglycan.—J. Bacteriol.116: 1029–1053.

    PubMed  CAS  Google Scholar 

  • Lugtenberg, E. J. J. 1972. Studies onEscherichia coli enzymes involved in the synthesis of uridine diphosphate-N-acetyl-muramyl-pentapeptide.—J. Bacteriol.110: 26–34.

    PubMed  CAS  Google Scholar 

  • Weinberg, E. D. 1974. Iron and susceptibility to infectious disease.—Science184: 952–956.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Failla, M.L., Benedict, C.D. & Weinberg, E.D. Bacterial and fungal growth in total parenteral nutrition solutions. Antonie van Leeuwenhoek 41, 319–328 (1975). https://doi.org/10.1007/BF02565066

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02565066

Keywords

Navigation